Page 429 - Read Online
P. 429

Linger et al. Vessel Plus 2020;4:36  I  http://dx.doi.org/10.20517/2574-1209.2020.51                                                 Page 7 of 9

               suite, bypassing both the emergency department and conventional CT scanner [54,55] . A flat panel CT using
               angiography equipment (or in some cases a separate CT scanner in the angio-suite) can be used to exclude
               intracerebral hemorrhage, followed by diagnostic angiography and treatment if a LVO is detected. In one
               observational study, this resulted in significantly shorter median door-to-arterial access times (16 min
               vs. 70 min; P < 0.01) and greater functional independence at 90 days (defined as mRS 0-2; 41 vs. 28%; P
                     [55]
               = 0.05) . However, whether this is an efficient use of limited angiography suite resources remains to be
               determined.

               CONCLUSIONS AND FUTURE DIRECTIONS
               Effective and rapid reperfusion remains the only proven approach to reduce disability in ischemic stroke
               patients. Thrombectomy has been a major advance, and the indications continue to broaden. Device
               evolution is likely to continue and the emphasis for technical procedural success is now on rapid “first
                                           [56]
               pass” near-complete reperfusion . Mild stroke, distal occlusion and patients with large ischemic core are
               the current frontiers on which randomized trials are focused. Neuroprotection may yet prove beneficial
               with a recent trial of nerinetide being neutral overall but suggesting benefit in patients who did not receive
                          [57]
               thrombolysis . Systems of care innovations to accelerate treatment are highly achievable and of critical
               importance to continue to reduce the disability associated with LVO ischemic stroke.


               DECLARATIONS
               Authors’ contributions
               Made substantial contributions to conception and design of the commentary and performed data
               interpretation: Linger M, Campbell BCV

               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2020.

               REFERENCES
               1.   Berkhemer OA, Fransen PS, Beumer D, et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic
                   stroke. N Engl J Med 2015;372:11-20.
               2.   Campbell BC, Mitchell PJ, Kleinig TJ, et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-
                   imaging selection. N Engl J Med 2015;372:1009-18.
               3.   Goyal M, Demchuk AM, Menon BK, et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of
                   ischemic stroke. N Engl J Med 2015;372:1019-30.
               4.   Saver JL, Goyal M, Bonafe A, et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in
                   stroke. N Engl J Med 2015;372:2285-95.
   424   425   426   427   428   429   430   431   432   433   434